Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women

International Journal of STD and AIDS

Volumn 14, Issue 12, 2003, Pages 826-829

  Natividad Villanueva, G U ^a   Santiago, E ^b   Manalastas Jr , R M ^a   Brown, H W ^d   Ingersoll, J ^c   Caliendo, A M ^c   Mayer, K H ^d   Cu Uvin, S ^d  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b San Lazaro Hospital   (Philippines)

^c EMORY UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Cervicovaginal; Genital tract; HIV 1 RNA; Shedding

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CERVICOVAGINAL LAVAGE; CLINICAL ARTICLE; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAVAGE; LYMPHOCYTE COUNT; PHILIPPINES; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PHILIPPINES; RNA, VIRAL; VAGINA; VAGINAL SMEARS; VIRAL LOAD;

EID: 0346753425     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203322556165     Document Type: Article

References (31)

1. UNAIDS & World Health Organization. AIDS Epidemic Report: Global Estimates, 1999 update. (www.unaids.org/ epidemicupdate/report/ Epireportchapgloestim.htm)
2. UNAIDS & World Health Organization. Philippines Epidemiological Fact Sheet on HIV/AIDS and sexually transmitted infections, 2000 update. (www.unaids.org)
3. Philippine Department of Health. National HIV/AIDS Registry. Monthly update May, 2001. (www.doh.gov.ph/ NECwpage/hivaids.htm)
4. Centers for Disease Control and prevention. AIDS in Women. U.S. 1994. MMWR 1995;44:81-4
5. Cu-Uvin S, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol 1997;90:739-43
6. Vogt MW, Witt DJ, Craven D, et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1:525-7
7. Vogt MW, Witt DJ, Craven D, et al. Isolation patterns of HIV from cervical secretions during the menstrual cycle of women at risk for AIDS. Ann Intern Med 1987;106:380-2
8. Wofsby CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retroviruses from genital secretions of women with antibodies to the virus. Lancet 1986;1:527-9
9. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989;160:380-4
10. Goulston C, Stevens E, Gallo D, Mullins JI, Hanson C, Katzenstein D. Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle. J Infect Dis 1996;174:858-61
11. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269:2860-4
12. Critchlow CW, Kiviat NB. Detection of human immunodeficiency virus type 1 and type 2 in the female genital tract: Implications for the understanding of virus transmission. Obstet Gynecol Surv 1997;52:315-24
13. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997;11:F85-93
14. Kovacs A, Chan LS, Chen ZC, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. JAIDS 1999;22:124-31
15. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;179:871-82
16. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 2000;14:415-21
17. Debiaggi M, Zara F, Spinillo A, et al. Viral excretion in cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2001;20:91-6
18. Coombs RW, Wright DJ, Reichelderfer PS, et al. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis 2001;184:1187-91
19. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001;358:1593-601
20. Seck K, Samb N, Tempesta S, et al. Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal. Sex Transm Infect 2001;77:190-3
21. Mostad SB, Kreiss JK. Shedding of HIV-1 in the genital tract. AIDS 1996;10:1305-15
22. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;9082:922-7
23. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the genital tract. J Infect Dis 1998;177:1100-3
24. Iversen AKN, Larsen AR, Jensen T, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998;177:1214-20
25. Shaheen F, Sison AV, McIntosh L, Mukhtar M, Pomerantz RJ. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Hum Virol 1999;2:154-66
26. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. AIDS 2000;14:2101-7
27. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV-1 in 563 stable couples. BMJ 1992;304: 809-13
28. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921-9
29. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine on viral load. JAMA 1996;275:599-605
30. Mofenson LM, Lambert JS, Steihm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999;341:385-93
31. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999;341:394-402